3 completed, 3 recruiting, 1 enrolling by invitation. 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 4 | 1 | Recruiting 1 |
Follow AV-1451: new trials by email Literature Review of AV-1451 trials Research Report on AV-1451
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alzheimer's Disease Neuroimaging Initiative 4 Neuraceq, Amyvid, Tauvid - Mild Cognitive Impairment, Alzheimer Disease | Enrolling by invitation | University of Southern California | 1500 | 2023-06-09 | 2026-09-29 | |
| Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU) AV-1451 - Alzheimer's Disease | Recruiting | University of Pennsylvania | 100 | 2023-03-14 | 2026-09-04 | |
| Depression and Driving F 18 AV-1451 (Flortaucipir), [11C]-Pittsburgh Compound B ([11C]PiB) - Depression, Drive | Recruiting | Washington University School of Medicine | 150 | 2021-06-17 | 2026-06-08 | |
| Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech AV-1451 - PPA, Non-fluent Aphasia | Phase 4 | Recruiting | Mayo Clinic | 50 | 2018-07-01 | 2025-11-12 |
| A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease LY3303560 - IV, Placebo - IV, Florbetapir F 18 - Alzheimer Disease | Phase 1 | Completed | Eli Lilly and Company | 22 | 2017-01-31 | 2023-10-10 |
| Tau PET Imaging in Atypical Dementias 18F-AV-1451, PET - Primary Progressive Aphasia With Suspected Alzheimer's Disease | Phase 1 | Completed | University of Chicago | 70 | 2016-02-01 | 2025-04-06 |
| Tau Imaging in Young Onset Dementia [18F]-T807 imaging tracer - Alzheimer's Disease, Early Onset, Logopenic Progressive Aphasia | Completed | University of Pennsylvania | 16 | 2014-11-01 | 2020-03-25 |
Alzheimer Disease (4) · Aphasia (1) · Aphasia, Broca (1) · Aphasia, Primary Progressive (1) · Apraxias (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Dementia (1) · Depression (1) · Pick Disease of the Brain (1) · Plaque, Amyloid (1) · Primary Progressive Nonfluent Aphasia (1)
University of Pennsylvania (2) · Eli Lilly and Company (1) · Mayo Clinic (1) · University of Chicago (1) · University of Southern California (1) · Washington University School of Medicine (1)
United States (7) · Canada (1) · Japan (1) · United Kingdom (1)
Beau Ances, MD, PhD (1) · David A. Wolk (1) · David Wolk, MD (1) · Emily Rogalski, Ph.D. (1) · Jennifer Whitwell, PhD (1) · Michael Weiner, MD (1) · Paul Aisen, MD (1) · Ronald Petersen, MD, PHD (1) · Sandhitsu R. Das (1)
2016 (1), R01AG056258 (1), R01DC012519 (1), U19AG024904 (1)